Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia-Reference-Cited by-同舟云学术

Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia

Published:2013-04-14 Issue:4 Volume:17 Page:326-327
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:

Author:

Hussein Ayad A.¹,Frangoul Haydar²

Affiliation:

1. Bone Marrow and Stem Cell Transplantation Program; King Hussein Cancer Center (KHCC); Amman; Jordan

2. Pediatric Stem Cell Transplant Program; Monroe Carell Jr. Children's Hospital at Vanderbilt; Nashville; TN; USA

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.12088/fullpdf

Reference15 articles.

1. Aplastic anaemia treated by marrow transplantation;Thomas;Lancet,1972

2. Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis);Stucki;Blood,1998

3. Long-term outcome of acquired aplastic anaemia in children: Comparison between immunosuppressive therapy and bone marrow transplantation;Kojima;Br J Haematol,2000

4. Favorable outcome with allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia patients;Unal;Pediatr Transplant,2007

5. Management of acquired aplastic anemia in children;Korthof;Bone Marrow Transplant,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Intensity Conditioning, Combined Transplantation of Haploidentical Hematopoietic Stem Cells and Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia;PLoS ONE;2014-03-03